Cristina Montagna

Author PubWeight™ 67.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 2006 6.37
2 Comparative isoschizomer profiling of cytosine methylation: the HELP assay. Genome Res 2006 5.99
3 PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab. Cancer Res 2008 3.98
4 Dynamic sorting of nuclear components into distinct nucleolar caps during transcriptional inhibition. Mol Biol Cell 2005 2.36
5 KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors. Cell 2013 2.34
6 Of mice and MEN1: Insulinomas in a conditional mouse knockout. Mol Cell Biol 2003 2.12
7 Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol 2005 2.07
8 Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations. Blood 2012 1.98
9 STAT4 serine phosphorylation is critical for IL-12-induced IFN-gamma production but not for cell proliferation. Proc Natl Acad Sci U S A 2002 1.69
10 Genetic dosage compensation in a family with velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome. Am J Med Genet A 2011 1.54
11 Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer. Oncogene 2002 1.42
12 Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS. Blood 2012 1.36
13 Septin roles in tumorigenesis. Biol Chem 2011 1.24
14 Hormone-induced chromosomal instability in p53-null mammary epithelium. Cancer Res 2004 1.21
15 Loss of polycystin-1 causes centrosome amplification and genomic instability. Hum Mol Genet 2008 1.20
16 Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors. Oncotarget 2011 1.19
17 Loss of CCAAT/enhancer binding protein delta promotes chromosomal instability. Oncogene 2004 1.16
18 Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression. Breast Cancer Res 2011 1.13
19 SMC1 involvement in fragile site expression. Hum Mol Genet 2005 1.11
20 Haploinsufficiency of Anx7 tumor suppressor gene and consequent genomic instability promotes tumorigenesis in the Anx7(+/-) mouse. Proc Natl Acad Sci U S A 2003 1.01
21 Inhibition of BUB1 results in genomic instability and anchorage-independent growth of normal human fibroblasts. Cancer Res 2003 1.00
22 Chromosome-specific accumulation of aneuploidy in the aging mouse brain. Hum Mol Genet 2012 1.00
23 Two replication fork maintenance pathways fuse inverted repeats to rearrange chromosomes. Nature 2013 0.99
24 Cell fusion is a physiological process in mouse liver. Hepatology 2008 0.98
25 An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression. Cancer Res 2009 0.97
26 Chromosomal aneuploidy in the aging brain. Mech Ageing Dev 2011 0.95
27 RAD51 mutants cause replication defects and chromosomal instability. Mol Cell Biol 2012 0.91
28 Therapeutically targeting cyclin D1 in primary tumors arising from loss of Ini1. Proc Natl Acad Sci U S A 2010 0.90
29 Atm heterozygosity cooperates with loss of Brca1 to increase the severity of mammary gland cancer and reduce ductal branching. Cancer Res 2005 0.89
30 E6 and E7 oncoproteins induce distinct patterns of chromosomal aneuploidy in skin tumors from transgenic mice. Cancer Res 2004 0.89
31 Dendritic cell-mediated in vivo bone resorption. J Immunol 2010 0.87
32 Silencing of the Il2 gene transcription is regulated by epigenetic changes in anergic T cells. Eur J Immunol 2012 0.87
33 Prognostic and predictive value of 16p12.1 and 16q22.1 copy number changes in human breast cancer. Cancer Genet Cytogenet 2010 0.85
34 Molecular cytogenetics of mouse models of breast cancer. Breast Dis 2004 0.85
35 A mammary-specific, long-range deletion on mouse chromosome 11 accelerates Brca1-associated mammary tumorigenesis. Neoplasia 2008 0.84
36 Spectral karyotyping in cancer cytogenetics. Methods Mol Med 2002 0.84
37 Septin 9 amplification and isoform-specific expression in peritumoral and tumor breast tissue. Biol Chem 2014 0.82
38 Recapitulation of the Roberts syndrome cellular phenotype by inhibition of INCENP, ZWINT-1 and ZW10 genes. Gene 2004 0.81
39 DNA methylation changes in murine breast adenocarcinomas allow the identification of candidate genes for human breast carcinogenesis. Mamm Genome 2011 0.80
40 Msh6 protects mature B cells from lymphoma by preserving genomic stability. Am J Pathol 2010 0.80
41 Toxicological and biochemical response to azinphos-methyl in Cydia pomonella L. (Lepidoptera: Tortricidae) among orchards from the Argentinian Patagonia. Pest Manag Sci 2008 0.80
42 Tissue-specific sensitivity to AID expression in transgenic mouse models. Gene 2006 0.80
43 Single-cell analysis of ploidy and centrosomes underscores the peculiarity of normal hepatocytes. PLoS One 2011 0.79
44 Highlight: the 5th International Workshop on Septin Biology. Biol Chem 2014 0.78
45 Analysis of 41 cancer cell lines reveals excessive allelic loss and novel mutations in the SIRT1 gene. Cell Cycle 2012 0.78
46 Seeking truth on Monte Verita. Workshop on the molecular biology and biochemistry of septins and septin function. EMBO Rep 2007 0.78
47 Four-color FISH for the detection of low-level aneuploidy in interphase cells. Methods Mol Biol 2014 0.78
48 Advanced molecular cytogenetics in human and mouse. Expert Rev Mol Diagn 2004 0.78
49 Inhibition of Plk1 and Cyclin B1 expression results in panobinostat-induced G₂ delay and mitotic defects. Sci Rep 2013 0.77
50 Translating the TCGA breast cancer results into clinical practice: searching for therapeutic clues. Oncology (Williston Park) 2013 0.77
51 SMC1 inhibition results in FRA3B expression but has no effect on its delayed replication. Mutat Res 2006 0.76
52 A syndrome of holoprosencephaly, recurrent infections, and monocytosis. Am J Med Genet A 2006 0.75